companydata.dkcompanydata.dk

PHARMAVIE A/S: Financial statements 2023

CVR: 26553148

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

PHARMAVIE A/S (CVR 26553148) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 334,718 and a net result of DKK -4,394,295 compared with DKK -1,077,009 the year before. That is an increase of 1.2% compared with the year before. Equity in the 2023 report amounted to DKK -3,403,806. The company had 1 employee in the financial year.

Gross Profit
DKK 334,718
Profit/Loss
DKK -4,394,295
Equity
DKK -3,403,806
Total Assets
DKK 9,525,000
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-335K-4.4M-3.4M1
2022-331K-1.1M990K1
2021-246K1.4M2.1M-
2020--173K6K712K1
2019--241K-1.3M706K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

PHARMAVIE A/S: The 2022 annual report is outJun 30, 2023

PHARMAVIE A/S has published its annual report for 2022. Gross profit came to DKK 330,758, and the net result was DKK -1,077,009.

About PHARMAVIE A/S

PHARMAVIE A/S is a Danish company of the type Aktieselskab based in Greve, founded in 2002. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named PHARMAVIE CONSULT A/S. The management consists of Carsten Wærn. The board consists of Margit Wærn (chair), Carsten Wærn and Vibeke Wærn. The company is owned by MAW HOLDING ApS and VIPS HOLDING ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. Equity in the 2025 report amounted to DKK -978,681.

Source: annual report 2025, Danish Business Authority